Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector By: Benzinga via Benzinga July 03, 2014 at 12:26 PM EDT Large-cap biotech stocks should see healthy second-quarter results driven by strong demand and new products, a Citi analyst said ... Read More >> Related Stocks: Alexion Pharmaceuticals Amgen Biogen Idec Celgene Corp Gilead Sciences Regeneron Pharmaceuticals